Niemann Pick C1 Like Protein 1 Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

1 RESEARCH SCOPE

1.1 Research Product Definition

1.2 Research Segmentation

1.2.1 Product Type

1.2.2 Main product Type of Major Players

1.3 Demand Overview

1.4 Research Methodology

2 GLOBAL NIEMANN PICK C1 LIKE PROTEIN 1 INDUSTRY

2.1 Summary about Niemann Pick C1 Like Protein 1 Industry

2.2 Niemann Pick C1 Like Protein 1 Market Trends

2.2.1 Niemann Pick C1 Like Protein 1 Production & Consumption Trends

2.2.2 Niemann Pick C1 Like Protein 1 Demand Structure Trends

2.3 Niemann Pick C1 Like Protein 1 Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020

3.2 Market Development under the Impact of COVID-19

3.2.1 Drivers

3.2.2 Restraints

3.2.3 Opportunity

3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)

4.1.1 North America (U.S., Canada and Mexico)

4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)

4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)

4.1.4 South America (Brazil,, Argentina, Rest of Latin America)

4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)

4.2 Product Type Segmentation (2017 to 2021f)

4.2.1 KT-6971

4.2.2 HS-25

4.2.3 Bempedoic Acid

4.2.4 Ezetimibe

4.2.5 Others

4.3 Consumption Segmentation (2017 to 2021f)

4.3.1 Hospital

4.3.2 Clinic

4.3.3 Others

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)

5.1.1 U.S.

5.1.2 Canada

5.1.3 Mexico

5.2 Product Type Segmentation (2017 to 2021f)

5.2.1 KT-6971

5.2.2 HS-25

5.2.3 Bempedoic Acid

5.2.4 Ezetimibe

5.2.5 Others

5.3 Consumption Segmentation (2017 to 2021f)

5.3.1 Hospital

5.3.2 Clinic

5.3.3 Others

5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)

6.1.1 Germany

6.1.2 UK

6.1.3 France

6.1.4 Italy

6.1.5 Rest of Europe

6.2 Product Type Segmentation (2017 to 2021f)

6.2.1 KT-6971

6.2.2 HS-25

6.2.3 Bempedoic Acid

6.2.4 Ezetimibe

6.2.5 Others

6.3 Consumption Segmentation (2017 to 2021f)

6.3.1 Hospital

6.3.2 Clinic

6.3.3 Others

6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)

7.1.1 China

7.1.2 India

7.1.3 Japan

7.1.4 South Korea

7.1.5 Southeast Asia

7.1.6 Australia

7.1.7 Rest of Asia Pacific

7.2 Product Type Segmentation (2017 to 2021f)

7.2.1 KT-6971

7.2.2 HS-25

7.2.3 Bempedoic Acid

7.2.4 Ezetimibe

7.2.5 Others

7.3 Consumption Segmentation (2017 to 2021f)

7.3.1 Hospital

7.3.2 Clinic

7.3.3 Others

7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)

8.1.1 Brazil

8.1.2 Argentina

8.1.3 Rest of Latin America

8.2 Product Type Segmentation (2017 to 2021f)

8.2.1 KT-6971

8.2.2 HS-25

8.2.3 Bempedoic Acid

8.2.4 Ezetimibe

8.2.5 Others

8.3 Consumption Segmentation (2017 to 2021f)

8.3.1 Hospital

8.3.2 Clinic

8.3.3 Others

8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)

9.1.1 GCC

9.1.2 North Africa

9.1.3 South Africa

9.1.4 Rest of Middle East and Africa

9.2 Product Type Segmentation (2017 to 2021f)

9.2.1 KT-6971

9.2.2 HS-25

9.2.3 Bempedoic Acid

9.2.4 Ezetimibe

9.2.5 Others

9.3 Consumption Segmentation (2017 to 2021f)

9.3.1 Hospital

9.3.2 Clinic

9.3.3 Others

9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players

10.1.1 Alvogen Korea Co Ltd

10.1.2 Chong Kun Dang Pharmaceutical Corp

10.1.3 Esperion Therapeutics Inc

10.1.4 Kotobuki Pharmaceutical Co Ltd

10.1.5 Merck & Co Inc

10.1.6 Zhejiang Hisun Pharmaceutical Co Ltd

10.2 Niemann Pick C1 Like Protein 1 Sales Date of Major Players (2017-2020e)

10.2.1 Alvogen Korea Co Ltd

10.2.2 Chong Kun Dang Pharmaceutical Corp

10.2.3 Esperion Therapeutics Inc

10.2.4 Kotobuki Pharmaceutical Co Ltd

10.2.5 Merck & Co Inc

10.2.6 Zhejiang Hisun Pharmaceutical Co Ltd

10.3 Market Distribution of Major Players

10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region

11.2 Forecast by Demand

11.3 Environment Forecast

11.3.1 Impact of COVID-19

11.3.2 Geopolitics Overview

11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT

Table Niemann Pick C1 Like Protein 1 Product Type Overview

Table Niemann Pick C1 Like Protein 1 Product Type Market Share List

Table Niemann Pick C1 Like Protein 1 Product Type of Major Players

Table Brief Introduction of Alvogen Korea Co Ltd

Table Brief Introduction of Chong Kun Dang Pharmaceutical Corp

Table Brief Introduction of Esperion Therapeutics Inc

Table Brief Introduction of Kotobuki Pharmaceutical Co Ltd

Table Brief Introduction of Merck & Co Inc

Table Brief Introduction of Zhejiang Hisun Pharmaceutical Co Ltd

Table Products & Services of Alvogen Korea Co Ltd

Table Products & Services of Chong Kun Dang Pharmaceutical Corp

Table Products & Services of Esperion Therapeutics Inc

Table Products & Services of Kotobuki Pharmaceutical Co Ltd

Table Products & Services of Merck & Co Inc

Table Products & Services of Zhejiang Hisun Pharmaceutical Co Ltd

Table Market Distribution of Major Players

Table Global Major Players Sales Revenue (Million USD) 2017-2020e

Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e

Table Global Niemann Pick C1 Like Protein 1 Market Forecast (Million USD) by Region 2021f-2026f

Table Global Niemann Pick C1 Like Protein 1 Market Forecast (Million USD) Share by Region 2021f-2026f

Table Global Niemann Pick C1 Like Protein 1 Market Forecast (Million USD) by Demand 2021f-2026f

Table Global Niemann Pick C1 Like Protein 1 Market Forecast (Million USD) Share by Demand 2021f-2026f